Bayer and Recursion focus research collaboration on Oncology
Digitally enabled drug discovery for oncology with potential to accelerate the delivery of new cancer therapies to patients
Digitally enabled drug discovery for oncology with potential to accelerate the delivery of new cancer therapies to patients
European operations' revenue grew 58.4% to Rs 599.7 crore
The drug will be marketed by Sun Pharma under the brand name RYTSTAT
Nanoform will receive access to compound libraries and large data sets to undertake STARMAP screening
Astria will assume full cost and responsibility for the global development and commercialization of the licensed therapeutic program for all indications
Glenmark will receive from Cassiopea, a subsidiary of Cosmo, the exclusive right to commercialize Winlevi in 15 EU countries
The AGE1.CR.pIX cell line's versatility allows it to support a wide range of viruses and vaccine types
The non-enzymatic electrochemical sensing strip can simultaneously detect the direct and total bilirubin in a single drop of blood, and provide the concentrations within a minute
The primary purpose of this collaboration is to bring the optimized protein into the Indian market
Subscribe To Our Newsletter & Stay Updated